Peer-Reviewed Publication
Ann Thorac Surg2026October 16, 2026Journal Article

Transcarotid Access for Transcatheter Aortic Valve Replacement With the Evolut Self-Expanding Valve: Outcomes from a Real-World Registry.

Keith B Allen1, Chetan Huded2, David J Cohen3, Michael Reardon4, John Saxon5, Thomas Modine6, Lionel Leroux7, Gaetano Paone8, Clinton Kemp9, Ruth Eisenberg10, Elizabeth Grier2, Adnan K Chhatriwalla2
1St. Luke's Mid America Heart Institute, Kansas City, MO, United States. Electronic address: kallen2340@aol.com.
2St. Luke's Mid America Heart Institute, Kansas City, MO, United States.
3Cardiovascular Research Foundation, New York, NY and St. Francis Hospital, Roslyn, NY, United States.
4Houston Methodist Debakey Heart & Vascular Center, Houston, TX, United States.
5University Of Virginia, Charlottesville, VA, United States.
6Université de Bordeaux, Bordeaux, France.
7Hôpital Cardiologique du Haut-Lévêque, Pessac, France.
8Emory University Atlanta, Atlanta, GA, United States.
9Sentara Health, Norfolk, VA, United States.
10Structural Heart, Medtronic, Minneapolis, MN, United States.

Abstract

BACKGROUND: Transcarotid access for transcatheter aortic valve replacement (TAVR) is the most commonly used alternate access in the United States. Real-world evidence on transcarotid access using the Evolut self-expanding valve based on larger numbers of patients may help inform treatment optimization towards better outcomes. METHODS: The Society of Thoracic Surgeons/American College of Cardiolog…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.